BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12860030)

  • 1. Validation of a sensitive and automated 96-well solid-phase extraction liquid chromatography-tandem mass spectrometry method for the determination of desloratadine and 3-hydroxydesloratadine in human plasma.
    Yang L; Clement RP; Kantesaria B; Reyderman L; Beaudry F; Grandmaison C; Di Donato L; Masse R; Rudewicz PJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(2):229-40. PubMed ID: 12860030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of desloratadine and its active metabolite 3-hydroxydesloratadine in human plasma by LC/MS/MS and its application to pharmacokinetics and bioequivalence.
    Xu HR; Li XN; Chen WL; Chu NN
    J Pharm Biomed Anal; 2007 Nov; 45(4):659-66. PubMed ID: 17936534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of an improved LC-MS/MS method for the quantification of desloratadine and its metabolite in human plasma using deutrated desloratadine as internal standard.
    Hasnain MS; Rao S; Singh MK; Vig N; Singh MK; Budakoti SK; Ansari A
    J Pharm Bioallied Sci; 2013 Jan; 5(1):74-9. PubMed ID: 23559828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthogonal extraction/chromatography and UPLC, two powerful new techniques for bioanalytical quantitation of desloratadine and 3-hydroxydesloratadine at 25 pg/mL.
    Shen JX; Wang H; Tadros S; Hayes RN
    J Pharm Biomed Anal; 2006 Feb; 40(3):689-706. PubMed ID: 16095862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of G-856 (Cur-61414) in human plasma using semi-automated solid phase extraction.
    Shin YG; Murakami SC; Buonarati MH; Dean B; Hop CE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():85-92. PubMed ID: 22317788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of GDC-0152 in human plasma using solid-phase extraction.
    Shin YG; Jones SA; Murakami SC; Budha N; Ware J; Wong H; Buonarati MH; Dean B; Hop CE
    Biomed Chromatogr; 2013 Jan; 27(1):102-10. PubMed ID: 22623056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a liquid chromatography-triple quadrupole mass spectrometric method for the determination of 5-nitro-5'-hydroxy-indirubin-3'-oxime (AGM-130) in human plasma and its application to microdose clinical trial.
    Park MH; Lee YY; Cho KH; La S; Lee HJ; Yim DS; Ban S; Park MY; Kim YC; Kim YG; Shin YG
    Biomed Chromatogr; 2016 Mar; 30(3):323-9. PubMed ID: 26139072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of Desloratadine and Its Metabolite 3-OH Desloratadine in Human Plasma by LC-MS/MS].
    Zhang K; Zhang XQ; Lu W; Xie HR; He L; Jiang XH; Wang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 46(5):783-7, 804. PubMed ID: 26619557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of high-throughput liquid chromatography-tandem mass spectrometric method for simultaneous quantification of loratadine and desloratadine in human plasma.
    Srinubabu G; Patel RS; Shedbalkar VP; Rao AA; Rao MN; Bandaru VV
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Dec; 860(2):202-8. PubMed ID: 18006392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of loratadine and its active metabolite in human plasma by high-performance liquid chromatography with mass spectrometry detection.
    Vlase L; Imre S; Muntean D; Leucuta SE
    J Pharm Biomed Anal; 2007 Jul; 44(3):652-7. PubMed ID: 16962733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of hydrocodone and hydromorphone in human plasma by liquid chromatography with tandem mass spectrometric detection.
    Chen YL; Hanson GD; Jiang X; Naidong W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Mar; 769(1):55-64. PubMed ID: 11936695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of a novel KDR kinase inhibitor and its N-oxide metabolite in human plasma using 96-well solid-phase extraction and liquid chromatography/tandem mass spectrometry.
    Xu Y; Du L; Soli ED; Braun MP; Dean DC; Musson DG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(2):287-96. PubMed ID: 15686997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of GDC-0834 and its metabolite in human plasma using semi-automated 96-well protein precipitation.
    Shin YG; Jones SA; Murakami SC; Liu L; Wong H; Buonarati MH; Hop CE
    Biomed Chromatogr; 2012 Nov; 26(11):1444-51. PubMed ID: 22311651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of rupatadine and its metabolite desloratadine in human plasma by a sensitive LC-MS/MS method: application to the pharmacokinetic study in healthy Chinese volunteers.
    Wen J; Hong Z; Wu Y; Wei H; Fan G; Wu Y
    J Pharm Biomed Anal; 2009 Feb; 49(2):347-53. PubMed ID: 19059745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of GDC-0879 and its metabolite in dog plasma using solid phase extraction.
    Chou B; Adler RS; Meng M; Percey S; Dean B; Hop CE; Shin YG
    J Pharm Biomed Anal; 2012 Nov; 70():354-61. PubMed ID: 22717139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a highly sensitive LC-MS/MS method for simultaneous determination of rupatadine and its two active metabolites in human plasma: Application to a clinical pharmacokinetic study.
    Sun C; Li Q; Pan L; Liu B; Gu P; Zhang J; Ding L; Wu C
    J Pharm Biomed Anal; 2015; 111():163-8. PubMed ID: 25890211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated 96-well liquid-liquid back extraction liquid chromatography-tandem mass spectrometry method for the determination of ABT-202 in human plasma.
    Xu N; Kim GE; Gregg H; Wagdy A; Swaine BA; Chang MS; El-Shourbagy TA
    J Pharm Biomed Anal; 2004 Sep; 36(1):189-95. PubMed ID: 15351065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sensitive LC/MS/MS method using silica column and aqueous-organic mobile phase for the analysis of loratadine and descarboethoxy-loratadine in human plasma.
    Naidong W; Addison T; Schneider T; Jiang X; Halls TD
    J Pharm Biomed Anal; 2003 Aug; 32(4-5):609-17. PubMed ID: 12899951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of L-753,037 in human plasma by liquid chromatography/turbo ionspray tandem mass spectrometry.
    Zhao JJ; Xie I; Rogers JD
    J Mass Spectrom; 1999 Oct; 34(10):1018-27. PubMed ID: 10510424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation and application of an automated 96 -well solid-phase extraction liquid chromatography-tandem mass spectrometry method for the quantitative determination of SCH 201781 in human plasma.
    Yang L; Wu N; Rule GS; Campbell DA; Perkins JR; Rudewicz PJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):75-80. PubMed ID: 15354313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.